Canine epilepsy causes acute welfare harm during seizures and chronic welfare compromise from medication side effects, requiring careful long-term management to optimise quality of life.
Canine epilepsy welfare requires management of two distinct welfare challenges: the acute welfare harm of seizures and the chronic welfare effects of long-term medication. Seizures themselves cause acute welfare harm through the involuntary muscle contractions, loss of consciousness, and post-ictal (recovery) phase confusion and disorientation that can last minutes to hours. Dogs in the post-ictal phase may be temporarily blind, aggressive through confusion, or extremely anxious. Medication management, while essential to reduce seizure frequency, creates its own welfare trade-offs: phenobarbitone causes sedation, increased appetite leading to obesity, liver toxicity requiring regular monitoring, and potential personality changes. Some owners report that medication side effects are more impactful on daily quality of life than seizures that were previously infrequent. The welfare goal is not zero seizures at any medication cost, but the best quality of life achievable given the balance between seizure control and side effect burden. Owner education in recognising seizure triggers, appropriate first aid during seizures, and quality of life assessment tools enables informed management decisions that prioritise the dog's daily welfare experience.